Marc Ingenwerth

Essen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Escape From Synthetic T Cell Activator Tebentafusp by Genomic HLA Loss: A Case Report.

Escape From Synthetic T Cell Activator Tebentafusp by Genomic HLA Loss: A Case Report.

Journal: HLA

Published: February 01, 2026

Primary Angiosarcomas of the Thyroid: New Insights Into the Genetic Background and Potentially Targetable Therapeutic Markers of an Ultrarare Disease.

Primary Angiosarcomas of the Thyroid: New Insights Into the Genetic Background and Potentially Targetable Therapeutic Markers of an Ultrarare Disease.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: December 08, 2025

A subgroup of anaplastic thyroid carcinomas harbors MET alterations with potential therapeutic options.

A subgroup of anaplastic thyroid carcinomas harbors MET alterations with potential therapeutic options.

Journal: Pathology, research and practice

Published: May 14, 2025

Isolated abdominal wall metastasis 42 years after curative surgery for ovarian cancer: A case report.

Isolated abdominal wall metastasis 42 years after curative surgery for ovarian cancer: A case report.

Journal: Case reports in women's health

Published: January 23, 2025

Giant Uterine Leiomyoma Causing Severe Hemodynamic Instability.

Giant Uterine Leiomyoma Causing Severe Hemodynamic Instability.

Journal: O&G open

Published: September 18, 2024

Histopathologic, Molecular, and Clinical Profiling of Lymphoepithelioma-like Carcinoma of the Bladder.

Histopathologic, Molecular, and Clinical Profiling of Lymphoepithelioma-like Carcinoma of the Bladder.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: March 04, 2024

Bicenter validation of a risk model for the preoperative prediction of extraprostatic extension of localized prostate cancer combining clinical and multiparametric MRI parameters.

Bicenter validation of a risk model for the preoperative prediction of extraprostatic extension of localized prostate cancer combining clinical and multiparametric MRI parameters.

Journal: World journal of urology

Published: February 22, 2024

68Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy.

68Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: December 15, 2023

Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities.

Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: July 18, 2022

Prospective comparison of CT and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results.

Prospective comparison of CT and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results.

Journal: PloS one

Published: July 26, 2021

Multiparametric Integrated 18F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding.

Multiparametric Integrated 18F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding.

Journal: Cancers

Published: May 04, 2021

Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer.

Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 26, 2021

Showing 1-12 of 37

Last Updated: 09/26/2026